George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 526.00
Bid: 526.00
Ask: 527.00
Change: -3.00 (-0.57%)
Spread: 1.00 (0.19%)
Open: 530.00
High: 530.00
Low: 524.00
Prev. Close: 529.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AuM Update

12 Apr 2018 07:00

RNS Number : 6310K
Polar Capital Holdings PLC
12 April 2018
 

12 April 2018

 

 

Polar Capital Holdings plc

AuM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its quarterly update of its unaudited statement of its Assets under Management ("AuM") for the financial year to 31 March 2018.

 

Group AuM (unaudited)

 

Polar Capital reports that as at 31 March 2018 its AuM were £12.0bn compared to £9.3bn at the end of March 2017, an increase of 29% over the year. In the quarter, AuM increased by £0.3bn of which £525m were net inflows and £252m related to adverse market movement offset by fund outperformance.

 

AuM movement in twelve months to 31 March 2018

Long only

funds

Alternative funds

Total

AuM at 1 April 2017

£8,447m

£826m

£9,273m

Net subscriptions

£1,652m

£290m

£1,942m

Market movement

and performance

£713m

£52m

£765m

Total AuM at 31 March 2018

£10,812m

£1,168m

£11,980m

 

Comment

 

The Group is pleased to report a quarter of net inflows exceeding £0.5bn, resulting in annual net inflows of £1.9bn demonstrating that the momentum of net inflows over the past quarters has continued across a broad range of its fund strategies.

 

The quarter has brought significantly increased market volatility due to US inflationary concerns, the anticipation of the end of a prolonged recovery bull market cycle and increasing geo-political tension which have made the short-term market outlook less certain. Notwithstanding the above Polar is well placed to take advantage of market volatility given the breadth and compelling long-term performance of the firm's actively managed specialist investment strategies. 

 

The table below summarises the performance of the Group's Lipper ranked UCITS Fund AuM as at 31 March 2018 which make up 78% of Group AuM. Since inception, 99% of UCITS AuM is top quartile measured against the Lipper peer group and over five years 85% is first quartile with 13% of AuM in the second quartile. Over three years 78% is first quartile with 14% in the second quartile and over one year 62% is first quartile, 21% second quartile and 17% in the third and fourth quartiles.

 

 

1 year

3 years

5 years

Since

inception

1st quartile

62%

78%

85%

99%

2nd quartile

21%

14%

13%

1%

3rd and 4th quartile

17%

8%

2%

0%

 

Gavin Rochussen, Chief Executive, commented:

 

"Polar Capital has continued to deliver market beating performance for its clients and has benefitted from £1.9bn of net inflows for the year to 31 March 2018 lifting AuM by 29% from £9.3 bn to £12.0 bn.

 

As markets have become more volatile in the most recent quarter, Polar Capital's specialist actively managed funds have performed in line with expectations. The benefits of fundamental actively managed funds have been particularly well demonstrated in the significantly more volatile most recent quarter, with 82% of Group AuM performing ahead of benchmark.

 

With its broad range of specialist actively managed funds, Polar Capital is well placed to continue performing for its clients in what is likely to be a more volatile environment going forward."

 

Polar Capital will announce its results for the financial year to 31 March 2018 on the 25 June 2018.

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive Officer)John Mansell (Chief Operating Officer)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Andrew Buchanan

Margarita Mitropoulou

+44 (0)20 7523 8000

 

Peel Hunt - Joint Broker

Guy Wiehahn

+44 (0)20 7418 8893

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDEASLFFLEPEFF
Date   Source Headline
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.